Cross-Resistance of Escherichia coli RNA Polymerases Conferring Rifampin Resistance to Different Antibiotics
Authors:
Open Access
- 15 April 2005
- journal article
- research article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 187 (8) , 2783-2792
Abstract
In this study we further defined the rifampin-binding sites in Escherichia coli RNA polymerase (RNAP) and determined the relationship between rifampin-binding sites and the binding sites of other antibiotics, including two rifamycin derivatives, rifabutin and rifapentine, and streptolydigin and sorangicin A, which are unrelated to rifampin, using a purified in vitro system. We found that there is almost a complete correlation between resistance to rifampin (Rif r ) and reduced rifampin binding to 12 RNAPs purified from different rpoB Rif r mutants and a complete cross-resistance among the different rifamycin derivatives. Most Rif r RNAPs were sensitive to streptolydigin, although some exhibited weak resistance to this antibiotic. However, 5 out of the 12 Rif r RNAPs were partially resistant to sorangicin A, and one was completely cross-resistant to sorangicin A, indicating that the binding site(s) for these two antibiotics overlaps. Both rifampin and sorangicin A inhibited the transition step between transcription initiation and elongation; however, longer abortive initiation products were produced in the presence of the latter, indicating that the binding site for sorangicin A is within the rifampin-binding site. Competition experiments of different antibiotics with 3 H-labeled rifampin for binding to wild-type RNAP further confirmed that the binding sites for rifampin, rifabutin, rifapentine, and sorangicin A are shared, whereas the binding sites for rifampin and streptolydigin are distinct. Because Rif r mutations are highly conserved in eubacteria, our results indicate that this set of Rif r mutant RNAPs can be used to screen for new antibiotics that will inhibit the growth of Rif r pathogenic bacteria.Keywords
This publication has 42 references indexed in Scilit:
- In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutationsClinical Microbiology and Infection, 2004
- An Escherichia coli RNA Polymerase Defective in Transcription due to its Overproduction of Abortive Initiation ProductsJournal of Molecular Biology, 1994
- Genetic Evidence for the Interaction between Cluster I and Cluster III Rifampicin Resistant MutationsJournal of Molecular Biology, 1993
- Use of mono Q high resolution ion exchange chromatography to obtain highly pure and active Escherichia coli RNA polymeraseBiochemistry, 1990
- Effects of Rifampicin resistant rpoB mutations on antitermination and interaction with nusA in Escherichia coliJournal of Molecular Biology, 1988
- Characterization of the termination phenotypes of rifampicin-resistant mutantsJournal of Molecular Biology, 1988
- Mapping and sequencing of mutations in the Escherichia colirpoB gene that lead to rifampicin resistanceJournal of Molecular Biology, 1988
- Rifamycins: A General ViewAnnual Review of Microbiology, 1972
- A rifampicin resistent rna‐polymerase from E. coli altered in the β‐subunitFEBS Letters, 1969
- Mutations affecting RNA Polymerase associated with Rifampicin Resistance in Escherichia coliNature, 1968